Gefitinib-Enhanced Lung Fibrosis: Breakthroughs Set to Disrupt the Market by 2025–2030
Table of Contents Executive Summary: The State of Gefitinib-Enhanced Lung Fibrosis Research in 2025 Key Drivers and Restraints Shaping the Market Landscape Recent Scientific Breakthroughs and Their Clinical Implications Global…